Andrzej Bozek, Renata Kozłowska, Maciej Misiołek, Wojciech Ścierski, & Radosław Gawlik. (2022). Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAndrzej Bozek, Renata Kozłowska, Maciej Misiołek, Wojciech Ścierski, and Radosław Gawlik. Omalizumab Added to Allergen Immunotherapy Increased the Effect of Therapy in Patients with Severe Local Allergic Rhinitis. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationAndrzej Bozek, et al. Omalizumab Added to Allergen Immunotherapy Increased the Effect of Therapy in Patients with Severe Local Allergic Rhinitis. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.